BCM
BEAT

Brookstone Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Brookstone Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,559
Closed -$204K – 423
2018
Q1 		$204K Buy
+6,559
New +$216K 0.02% 330

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brookstone Capital Management's BEAT Position: Q2 2018 in Review

Brookstone Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2018, closing a stake of 6,559 shares — an estimated $204K sold.

Brookstone Capital Management first reported a position in BEAT in Q1 2018 and held it in 1 quarter. The position peaked at $204K in Q1 2018. 227 funds tracked by Wall St. Rank hold BEAT as of Q2 2018.

  • Brookstone Capital Management reported no remaining BioTelemetry, Inc. position as of Q2 2018 after selling out during the quarter.
  • Brookstone Capital Management sold 6,559 BioTelemetry, Inc. shares in Q2 2018, an estimated $204K.
  • Brookstone Capital Management first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 1 quarter.
  • Brookstone Capital Management's BioTelemetry, Inc. position peaked at $204K in Q1 2018.
  • 227 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2018.

Based on Brookstone Capital Management's 13F filing for Q2 2018, filed 6 Aug 2018.